Xenetic Biosciences, Inc. - stock earnings
XBIO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -1.1 million USD | 611174 USD |
| 2023Q2 | -1.1 million USD | 651005 USD |
| 2023Q1 | -797933 USD | 605844 USD |
| 2022Q4 | -1.4 million USD | 486972 USD |
| 2022Q3 | -760248 USD | 414250 USD |
| 2022Q2 | -2.6 million USD | 416710 USD |
| 2022Q1 | -1.5 million USD | 388993 USD |
| 2021Q4 | -1.8 million USD | 332604 USD |
| 2021Q3 | -1.4 million USD | 349269 USD |
| 2021Q2 | -1.1 million USD | 287603 USD |
| 2021Q1 | -1.3 million USD | 191216 USD |
| 2020Q4 | -1.2 million USD | 151332 USD |
| 2020Q3 | -7.6 million USD | 115934 USD |
| 2020Q2 | -953642 USD | 112927 USD |
| 2020Q1 | -1.2 million USD | 56749 USD |
| 2019Q4 | -1.2 million USD | 17066 USD |
| 2019Q3 | -8.9 million USD | ? USD |
| 2019Q2 | -1.4 million USD | ? USD |
| 2019Q1 | -1.3 million USD | ? USD |
| 2018Q4 | -1.6 million USD | ? USD |
| 2018Q3 | -1.8 million USD | ? USD |
| 2018Q2 | -2.0 million USD | ? USD |
| 2018Q1 | -1.8 million USD | 7.5 million USD |
| 2017Q4 | 4.4 million USD | 7.5 million USD |
| 2017Q3 | -2.3 million USD | 85000 USD |
| 2017Q2 | -2.9 million USD | ? USD |
| 2017Q1 | -2.9 million USD | ? USD |
| 2016Q4 | -391328 USD | 3.0 million USD |
| 2016Q3 | -2.5 million USD | ? USD |
| 2016Q2 | -47.8 million USD | ? USD |
| 2016Q1 | -3.6 million USD | ? USD |
| 2015Q4 | -3.6 million USD | ? USD |
| 2015Q3 | -5.3 million USD | ? USD |
| 2015Q2 | -1.1 million USD | ? USD |
| 2015Q1 | -4.3 million USD | ? USD |
| 2014Q4 | -4.3 million USD | ? USD |
| 2014Q3 | -3.2 million USD | ? USD |
| 2014Q2 | -2.8 million USD | ? USD |
| 2014Q1 | -4.1 million USD | ? USD |
| 2013Q4 | -82462 USD | 2169 USD |
| 2013Q3 | -76090 USD | -8039 USD |
| 2013Q2 | -13685 USD | 39415 USD |
| 2013Q1 | 15083 USD | 32560 USD |
| 2012Q4 | -14479 USD | 32964 USD |
| 2012Q3 | -43382 USD | 26640 USD |
| 2012Q2 | -38858 USD | 36430 USD |
| 2012Q1 | -29264 USD | 35967 USD |
| 2011Q4 | -29264 USD | 35967 USD |
| 2011Q3 | -18169 USD | 13749 USD |
XBIO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -4.4 million USD | 2.4 million USD |
| 2022 | -6.4 million USD | 1.7 million USD |
| 2021 | -5.5 million USD | 1.2 million USD |
| 2020 | -10.9 million USD | 436942 USD |
| 2019 | -15.9 million USD | 17066 USD |
| 2018 | -7.3 million USD | ? USD |
| 2017 | -3.6 million USD | 7.6 million USD |
| 2016 | -54.2 million USD | 3.0 million USD |
| 2015 | -12.5 million USD | ? USD |
| 2014 | -14.3 million USD | ? USD |
| 2013 | -8.6 million USD | 1.0 million USD |
| 2012 | -6.3 million USD | 293603 USD |
XBIO
Price: $4.30
52 week price:
Earnings Per Share: -2.71 USD
P/E Ratio: -1.31
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 27600
Ebitda: -8.4 millionMarket Capitalization: 6.8 million